Table 3.
Health-related QoL characteristics of the 455 HCC patients based on EORTC QLQ-C30 and EORTC QLQ-HCC18 assessment
| QoL variable | Mean | ±SD | Median | Min. | Max. |
|---|---|---|---|---|---|
| EORTC QLQ-C30 | |||||
| Physical functioning | 72.28 | 23.96 | 80.00 | 0.00 | 100.00 |
| Role functioning | 75.06 | 32.18 | 100.00 | 0.00 | 100.00 |
| Emotional functioning | 70.45 | 25.52 | 75.00 | 0.00 | 100.00 |
| Social functioning | 77.08 | 24.59 | 83.33 | 0.00 | 100.00 |
| Cognitive function | 68.58 | 30.28 | 66.67 | 0.00 | 100.00 |
| Global QoL | 52.53 | 26.38 | 50.00 | 0.00 | 100.00 |
| Fatigue | 42.56 | 29.81 | 33.33 | 0.00 | 100.00 |
| Nausea/vomiting | 11.01 | 21.28 | 0.00 | 0.00 | 100.00 |
| Pain | 32.10 | 31.55 | 33.33 | 0.00 | 100.00 |
| Dyspnoea | 29.74 | 31.27 | 33.33 | 0.00 | 100.00 |
| Insomnia | 40.90 | 35.87 | 33.33 | 0.00 | 100.00 |
| Appetite loss | 31.84 | 35.62 | 33.33 | 0.00 | 100.00 |
| Constipation | 16.63 | 26.72 | 0.00 | 0.00 | 100.00 |
| Diarrhea | 16.10 | 26.52 | 0.00 | 0.00 | 100.00 |
| Financial difficulties | 51.16 | 37.26 | 66.67 | 0.00 | 100.00 |
| C30 index score | 30.40 | 19.45 | 26.52 | 0.00 | 90.37 |
| EORTC QLQ-HCC18 | |||||
| Fatigue | 34.77 | 25.79 | 33.33 | 0.00 | 100.00 |
| Body image | 25.24 | 22.78 | 16.67 | 0.00 | 100.00 |
| Jaundice | 23.48 | 22.23 | 16.67 | 0.00 | 100.00 |
| Nutrition | 26.88 | 21.40 | 20.00 | 0.00 | 100.00 |
| Pain | 23.26 | 24.44 | 16.67 | 0.00 | 100.00 |
| Fever | 6.37 | 14.48 | 0.00 | 0.00 | 100.00 |
| Sex life | 28.31 | 34.40 | 0.00 | 0.00 | 100.00 |
| Abdominal swelling | 32.66 | 35.12 | 33.33 | 0.00 | 100.00 |
| HCC18 index score | 25.12 | 17.08 | 21.94 | 0.00 | 87.50 |
Abbreviations: EORTC, European Organization for Research and Treatment of Cancer; HCC, hepatocellular carcinoma; QoL, quality of life.